Drug interactions at the blood-brain barrier: Fact or fantasy?
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 123 (1), 80-104
- https://doi.org/10.1016/j.pharmthera.2009.03.017
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human GliomaJapanese Journal of Cancer Research, 2001
- Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicineLife Sciences, 1997
- Cellular localization of P-glycoprotein in brain versus gonadal capillaries.Journal of Histochemistry & Cytochemistry, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.JCI Insight, 1995
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Specialized Localization of P‐Glycoprotein Recognized by MRK 16 Monoclonal Antibody in Endothelial Cells of the Brain and the Spinal CordJapanese Journal of Cancer Research, 1990
- Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids.Journal of Pharmacobio-Dynamics, 1990
- The “On–Off” Phenomenon in Parkinson’s DiseaseThe New England Journal of Medicine, 1984
- Effect of Osmotic Blood-Brain Barrier Disruption on Methotrexate Pharmacokinetics in the DogNeurosurgery, 1980
- Barrier mechanisms for neurotransmitter monoamines in the choroid plexusActa Physiologica Scandinavica, 1980